Navigation Links
Reddick Grasper

ProductsReddick Grasper
Company Encision
Item Reddick Grasper
Features 
  • AEM Laparoscopic Instrument
  • Reusable Insert
  • Protective Shield
  • Primary Insulation Layer
  • Outer Insulation
  • Active Electrode Element
    • Description The 5mm AEM Laparoscopic Instruments incorporate a layered design unique in the industry. AEM Instruments are shielded and monitored to prevent stray electrosurgical burns along the shaft of the instrument caused by insulation failure or capacitive coupling; a well-documented patient safety risk. The protective shield built into all AEM Instruments provides a neutral return path for capacitively coupled energy and protection from insulation failure. The shield is continuously monitored during surgery which provides continuous assurance of the integrity of the instrument.

    Encision has a full line of AEM Surgical Instruments that are equivalent in function, ergonomics, size, shape, length and tip-styles as the conventional instruments that surgeons commonly use ... but with the added assurance of patient safety.
    Info Encision
    Customer Service: (303) 444-2600
    Web site: http://www.encision.com/

    Related medicine products :

    1. Reddick/Saye Needle Holder, Curved Left
    2. Reddick/Saye Needle Holder, Curved Right
    3. Reddick/Saye Needle Holder, Straight
    4. Shutt® Small Joint Graspers
    5. Small Joint Grasper
    6. Shutt® Suction Punch Foreceps/Suction Graspers
    7. Grasper, Blunt Straight Tip, 2.75 mm Straight Shaft
    8. Hannum Ronguer/Grasper
    9. 10mm Anvil Grasper
    10. Round Nose Grasper
    11. Standard Grasper
    A custom blend for Applied Biosystems by FMC. Designed specifically for the electrophoresis of PCR products.
    ...rs on the PK7200 Automated Microplate System, the ...latin particle for the detection of cytomegaloviru... assay as compared to EIA measures 99.8% and 99.3%...e carrier provides excellent lot-to-lot consistenc...
    The Ortho AutoVue System is an automated immunohematology testing system used for blood typing, antibody screening and compatibility testing using Ortho BioVue System cassettes.
    TANGO is designed for medium to large transfusion services, donor centers and reference laboratories performing ABO/Rh testing and antibody screening. It will perform a host of functions including bl
    Medicine Products:
    (Date:12/2/2008)...s establish special bonds between partners. Oftent...rships, and ultimately, the start of families. , ...o much emotional weight on their relationship. As ...self-worth solely based on the outcomes of their r...erm as relationship-contingent self-esteem (RCSE),...
    (Date:12/2/2008)...swire-USNewswire/ -- Today, advocates for teen,da...e coming together at Liz,Claiborne Inc. to launch...n,Dating Abuse. Ann and Chris Burke, educators an...y her abusive ex-boyfriend, are joining efforts wi...s national coalition that will,consist of parents...
    (Date:12/2/2008)...wire-USNewswire/ -- Today a group of health profe...fficials and other community leaders from more tha...ayne County to solidify participants, understandin...c successes and challenges play a role in determin...g session of a three-day discussion to consider ho...
    (Date:12/2/2008)...es a day linked to atrial fibrillation, study fin...-- A healthy middle-aged woman can have up to two ...normal heartbeat called atrial fibrillation, a new... M. Albert, a professor of medicine at Harvard Med...en,s Health study, looking for a relationship betw...
    Breaking Medicine News(10 mins):Health News:Too much commitment may be unhealthy for relationships, UH psychology professor says 2Health News:Parents of Murdered Dating Violence Victim, Legislators, and Teachers Unite to Launch 'MADE' - Moms and Dads for Education to Stop Teen Dating Abuse 2Health News:Parents of Murdered Dating Violence Victim, Legislators, and Teachers Unite to Launch 'MADE' - Moms and Dads for Education to Stop Teen Dating Abuse 3Health News:Think Tank Investigates the Environmental Conditions Surrounding Health Inequities 2Health News:Think Tank Investigates the Environmental Conditions Surrounding Health Inequities 3Health News:Light Drinking Poses No Heart Risk for Women 2
    ...duce fatty deposits that build up in the arteries ...e to reverse the development of heart disease // s...high doses of a powerful cholesterol-lowering drug...patients, including ten in Scotland. The two-year ...
    ...said that there would be a significant damage to a...a plan of action against the avian flu. // The IM...that a pandemic would trigger sharp fall in the pr...rism and trade would recede and lead to boycotting...
    ...land is in for a raise, and slated to go up by 15p...April, 2006. // The cost of a prescription now wil...arly ?430m extra in revenue. The charge for a pre...also be up by 75p - to ?34.65 for a period of four...
    ...lo have been able to identify two key components i...of oral bone loss in future. Oral bone loss is det...s vital to hold it in place. // Researchers compa... patients and related them with the levels of sali...
    Other Medicine News:Health News:Crestor to Prevent Heart Disease 2
    (Date:12/2/2008)...c. 2 Horizon Therapeutics, Inc., a...announced that two pivotal,Phase 3 trials evaluat...T-501,met all primary endpoints. HZT-501, a nove...taining ibuprofen and famotidine, demonstrated a,...ce of non-steroidal,anti-inflammatory drug (NSAID...
    (Date:12/1/2008)...1 TargeGen has announced that an o...ulti-center, US-based clinical,trial of TG101348 ...heduled at,the 2008 American Society of Hematolog...ation are as follows:, Title: A..., JAK2-Selective Inhibitor...
    (Date:12/1/2008)... is still the best policy , , ROCHESTER, M...y from Mayo Clinic finds the use of the drug thera...patitis, an acute inflammation of the liver caused...of the study are published in the December issue o...g/ ). , , VIDEO ALERT: Additional audio an...
    (Date:12/1/2008)...1 Vical Incorporated (Na....0 million milestone payment from Merck & Co.,...se I clinical trial of an investigational plasmid ...s based on Vical,s DNA gene delivery technology an...hTERT). hTERT is the subject of separate license a...
    Breaking Medicine Technology:Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2New Type of Stent Shows Promise 29498 1New Type of Stent Shows Promise 29498 2New Type of Stent Shows Promise 29498 3New Type of Stent Shows Promise 29498 4Interferon Reduces Eliminates Viral Infections in Heart Failure Patients 29494 1Interferon Reduces Eliminates Viral Infections in Heart Failure Patients 29494 2Interferon Reduces Eliminates Viral Infections in Heart Failure Patients 29494 3Type 2 Diabetics Studied in Low Dose Aspirin Trial 29492 1Type 2 Diabetics Studied in Low Dose Aspirin Trial 29492 2Type 2 Diabetics Studied in Low Dose Aspirin Trial 29492 3Type 2 Diabetics Studied in Low Dose Aspirin Trial 29492 4Tailored Drug Delivery Reduces Adverse Effects After PCI 29488 1Tailored Drug Delivery Reduces Adverse Effects After PCI 29488 2Tailored Drug Delivery Reduces Adverse Effects After PCI 29488 3
    ...s Shows Statistically Significant Changes in,Agita...March 26, 2007 /PRNewswire-FirstCall/ --,Alexza Ph...al,results from its Phase IIa clinical trial of AZ...nts with acute agitation. The 10 mg,dose of AZ-004...hich was a statistically-significant reduction in ...
    ...RE 2 Findings Suggest Improved Outcomes in Carotid...7 /PRNewswire-FirstCall/ --,Positive 30-day result...nting can be performed with positive results by,ph...n real-world,(non-clinical trial) settings in pati... Interim results from the first 1,500,patients enr...
    Other Medicine Technology:Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 2Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 3Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 4Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 5Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 6Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 2Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 3Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 4